Trump confirms Makary out at FDA
President Donald Trump confirmed on Tuesday that Marty Makary would be leaving his post atop the U.S. Food and Drug Administration.
While speaking to reporters on the White House lawn Tuesday, Trump said Makary would be leaving. He said FDA deputy commissioner Kyle Diamantes will take over as the adminsitration seeks a new leader of the federal agency.
“He was having some difficulty,” Trump said. “Marty is a terrific guy, but he’s going to go and lead a good life.”
Trump did not specify what kind of difficulty Makary experienced. Several reports circulated that there was an internal dispute over approval for flavored vapes at the FDA. The Wall Street Journal reported that Trump pressured Makary to approve fruit-flavored vapes, but he was hesitant to do so.
Trump said many people are seeking the job atop the agency.
Makary was expected to testify on Capitol Hill Wednesday to present the FDA’s budget for the upcoming fiscal year. Diamantes is expected to take his place.
Makary was confirmed to lead the FDA in March 2025. Since then, he’s sought to make several changes to the agency’s policies and change organizational structure. Makary sought to limit antidepressants for pregnant women and ban kratom byproducts.
“He’s a friend of mine, he’s a wonderful man and he’s going to be off,” Trump said of Makary.
Latest News Stories
Trump orders Department of War to begin testing nuclear weapons
WATCH: Tax proposals draw questions from Pritzker and GOP state rep
Illinois quick hits: Former sheriff’s deputy guilty in Massey murder; appeals court intervenes in Bavino case
WATCH: Warnings of higher IL property taxes heard as pension bill advances
Top-selling automaker confirms U.S. investment, but no details yet
Fentanyl poised to take center stage during Trump, Xi meeting
‘Outrageous’: Lawmakers bash Biden admin for targeting, surveilling 156 Republicans
WATCH: Cruz calls on House to impeach federal judge over subpoenas of Republicans
WATCH: Pritzker declares agricultural trade ‘crisis’ while Trump touts new deals
Economists say Trump’s tariff play could boost trade deficits
Amnesty International condemns U.S. strikes on suspected drug boats
Federal Reserve cuts key interest rate for second time this year